ADAGENE INC ADAG
ADS · ADR · CUSIP 005329107
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.46.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 12 |
| Q4 2022 | 10 |
| Q1 2023 | 12 |
| Q2 2023 | 11 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 0 | 5 |
| Q1 2023 | 4 | 2 |
| Q2 2023 | 2 | 5 |
Biggest buyers
| MORGAN STANLEY | Added | +46.1k |
| RHUMBLINE ADVISERS | New | +2.2k |
Biggest sellers
| FMR LLC | Reduced | -1.1m |
| Strategic Vision Investment Ltd | Reduced | -60.0k |
| CANNELL CAPITAL LLC | Sold out | -29.0k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -21.2k |
| CITADEL ADVISORS LLC | Sold out | -12.8k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Luo Peter
13D · may seek influence
-4.4 pts · filed 2026-06-08
Stated purposeOn May 23, 2025, Mr. Luo received 191,667 ordinary shares from Great Han Fortune LP for the benefit of Peter Luo, and Xiaohong She received 23,333 ordinary shares from Great Han Fortune LP for the benefit of Xiaohong She. On May 23, 2025, Mr. Luo and Xiaohong She transferred 191,667 and 23,333 ordinary shares respectively to HAN 2020 Irrevocable Trust, for estate planning purpose. Due to the operation of the Concert Party Agreement dated December 14, 2020 among members of Peter Luo-Acting-in-Concert-Group, Peter Luo may be deemed to acquire or dispose additional beneficial ownership from time to time due to the acquisition or disposal of beneficial ownership by the members of Peter Luo-Acting-in-Concert-Group. The Reporting Persons acquired the ordinary shares reported herein for invest… Full filing |
11.2% |
| JANUS HENDERSON GROUP PLC 13G · institution new · filed 2026-05-07 | 10.1% |
| Smith Vincent C 13G · passive investor +1.8 pts · filed 2026-01-29 | 8.7% |
| Chernett Jorey 13G · passive investor new · filed 2026-03-18 | 5.1% |
Fell to 5% or below in the last year: WuXi PharmaTech Healthcare Fund I L.P. (3.5%, 2026-08-14), GENERAL ATLANTIC, L.P. (0.0%, 2026-02-17)
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| HSG Holding Ltd 0.23% of their portfolio | 1.3m $2.0m | Unchanged |
| FMR LLC 0.00% of their portfolio | 1.1m $1.6m | Reduced -1.1m |
| Artal Group S.A. 0.05% of their portfolio | 1.0m $1.5m | Unchanged |
| Strategic Vision Investment Ltd 0.22% of their portfolio | 292.2k $432.5k | Reduced -60.0k |
| GENERAL ATLANTIC, L.P. 0.01% of their portfolio | 264.0k $390.7k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 55.3k $81.8k | Added +46.1k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 18.4k $27.0k | Reduced -21.2k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 10.3k $14.6k | Unchanged |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 2.2k $3.1k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 538 $796 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |